Literature DB >> 22340910

Game not over for sulodexide.

Sergio Coccheri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22340910     DOI： 10.1053/j.ajkd.2011.12.010

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  4 in total

Review 1.  Development and use of sulodexide in vascular diseases: implications for treatment.

Authors:  Sergio Coccheri; Ferdinando Mannello
Journal:  Drug Des Devel Ther       Date:  2013-12-24       Impact factor: 4.162

2.  Sulodexide for Diabetic-Induced Disabilities: A Systematic Review and Meta-Analysis.

Authors:  Angelo A Bignamini; Ahmed Chebil; Giovanni Gambaro; Jiří Matuška
Journal:  Adv Ther       Date:  2021-01-27       Impact factor: 3.845

Review 3.  Sulodexide therapy for the treatment of diabetic nephropathy, a meta-analysis and literature review.

Authors:  Rui Li; Jing Xing; Xaojing Mu; Hui Wang; Lei Zhang; Yu Zhao; Yu Zhang
Journal:  Drug Des Devel Ther       Date:  2015-12-03       Impact factor: 4.162

4.  Vorapaxar treatment reduces mesangial expansion in streptozotocin-induced diabetic nephropathy in mice.

Authors:  Maaike Waasdorp; JanWillem Duitman; Sandrine Florquin; C Arnold Spek
Journal:  Oncotarget       Date:  2018-04-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.